Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Teh Seng Pharmaceutical Mfg CoROCO:7860 +4.35%23 Interest Coverage is 58.29 as of Dec. 2025, which is 12% below its 10-year median of 66.19. GuruFocus rates ROCO:7860 with a GF Score™ of 23/100. The stock has 7 warning signs investors should review. Among 687 Drug Manufacturers companies, Teh Seng Pharmaceutical Mfg Co ranks better than 74.82% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Teh Seng Pharmaceutical Mfg Co's
Operating Income
for the
six
months ended in Dec. 2025 was NT$56.5 Mil. Teh Seng Pharmaceutical Mfg Co's Interest Expense for the
six
months ended in Dec. 2025 was NT$-1.0 Mil.
Teh Seng Pharmaceutical Mfg Co's interest coverage for the quarter that ended in Dec. 2025 was 58.29.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Teh Seng Pharmaceutical Mfg Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Teh Seng Pharmaceutical Mfg Co's Interest Coverage or its related term are showing as below:
ROCO:7860'
s Interest Coverage Range Over the Past 10 Years
Min: 36.64 Med: 66.19 Max: 69.92
Current: 66.19
ROCO:7860's Interest Coverage is ranked better than 74.82% of 687
companies
in the Drug Manufacturers industry
Industry Median: 12.75
vs ROCO:7860: 66.19
Teh Seng Pharmaceutical Mfg Co (ROCO:7860) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Teh Seng Pharmaceutical Mfg Co Interest Coverage Related Terms
Teh Seng Pharmaceutical Mfg Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Teh Seng Pharmaceutical Mfg Co Interest Coverage Chart
Teh Seng Pharmaceutical Mfg Co Annual Data
Trend
Dec23
Dec24
Dec25
Interest Coverage
36.64
69.92
66.19
Teh Seng Pharmaceutical Mfg Co Semi-Annual Data
Dec23
Jun24
Dec24
Jun25
Dec25
Interest Coverage
No Debt
50.89
87.56
72.82
58.29
ROCO:7860 vs ZTS, UTHR: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Teh Seng Pharmaceutical Mfg Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Teh Seng Pharmaceutical Mfg Co Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Teh Seng Pharmaceutical Mfg Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Teh Seng Pharmaceutical Mfg Co's Interest Coverage falls into.
Teh Seng Pharmaceutical Mfg Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Teh Seng Pharmaceutical Mfg Co (ROCO:7860) has a Interest Coverage of 58.29 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Teh Seng Pharmaceutical Mfg Co and its competitors. This is 12% below median its historical median of 66.19. Over the past decade, Teh Seng Pharmaceutical Mfg Co's Interest Coverage has ranged from 36.64 to 69.92. According to the industry distribution chart, Teh Seng Pharmaceutical Mfg Co ranks #173 out of 687 companies in the Drug Manufacturers industry, placing it in the top 25.2%.
Is Teh Seng Pharmaceutical Mfg Co's Interest Coverage too high?
Teh Seng Pharmaceutical Mfg Co's current Interest Coverage of 58.29 is 12% below median its 10-year median of 66.19. Over the past 10 years, this metric has ranged from a low of 36.64 to a high of 69.92. The Drug Manufacturers industry median Interest Coverage is 12.75. Teh Seng Pharmaceutical Mfg Co's value of 58.29 is 357.2% above this industry median. Based on the distribution chart, Teh Seng Pharmaceutical Mfg Co ranks #173 out of 687 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Teh Seng Pharmaceutical Mfg Co has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Teh Seng Pharmaceutical Mfg Co's Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Teh Seng Pharmaceutical Mfg Co ranks #173 out of 687 companies for Interest Coverage. This puts Teh Seng Pharmaceutical Mfg Co in the upper half of its industry. The industry median Interest Coverage is 12.75. Teh Seng Pharmaceutical Mfg Co's value of 58.29 is 357.2% above this benchmark. Historically, Teh Seng Pharmaceutical Mfg Co's own Interest Coverage has ranged from 36.64 to 69.92 over the past decade. While the company's 10-year median is 66.19 vs. the industry median of 12.75, Teh Seng Pharmaceutical Mfg Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.75, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Teh Seng Pharmaceutical Mfg Co's current Interest Coverage of 58.29 is 357.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Teh Seng Pharmaceutical Mfg Co and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Teh Seng Pharmaceutical Mfg Co's current Interest Coverage is 58.29, which is 12% below median its own 10-year median of 66.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teh Seng Pharmaceutical Mfg Co stock overvalued right now?
Teh Seng Pharmaceutical Mfg Co (ROCO:7860) has a current Interest Coverage of 58.29. The current Interest Coverage is 58.29, which is 12% below median its 10-year median of 66.19 and 357.2% above the Drug Manufacturers industry median of 12.75. Teh Seng Pharmaceutical Mfg Co's overall GF Score™ is 23/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Teh Seng Pharmaceutical Mfg Co (ROCO:7860), the current Interest Coverage is 58.29 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Teh Seng Pharmaceutical Mfg Co Business Description
Teh Seng Pharmaceutical Mfg Co Ltd is engaged in the development and manufacturing of various pain relieving patches, cosmetic patches and biotechnology products. Its products include: Hydrogel Patches, Oil-Based Patches, Hot-Melt Patches, CMO & CRO for Transdermal Patch, Oral Film & Sublingual, Cosmetic Patches, Biotechnology Products and Daily Supplements.
23GF Score
Get the complete analysis for ROCO:7860
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7860 has been successfully added to your 
